ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

ClinicalTrials.gov ID: NCT06850623

Public ClinicalTrials.gov record NCT06850623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Study identification

NCT ID
NCT06850623
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
EXACT Therapeutics AS
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • Acoustic Cluster Therapy Combination Product
  • Modified FOLFIRINOX Drug

Combination Product · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2025
Primary completion
Dec 14, 2026
Completion
Jul 14, 2027
Last update posted
Apr 2, 2026

2025 – 2027

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
HonorHealth Research Institute Scottsdale Arizona 85258 Recruiting
Stanford Cancer Center Palo Alto Stanford California 94305 Recruiting
Beth Israel Deaconess Medical Center - Division of Hematology/Oncology Boston Massachusetts 02215 Recruiting
Henry Ford Centre Detroit Michigan 48202 Recruiting
Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 Recruiting
Allegheny General Hospital Pittsburgh Pennsylvania 15212 Recruiting
Brown University Cancer Institute Providence Rhode Island 02906 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06850623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06850623 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →